methylselenic acid has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeMars, LC; Yan, L | 1 |
| Hu, H; Jiang, C; Kim, SH; Lee, HJ; Li, G; Lü, J; Wang, Z | 1 |
2 other study(ies) available for methylselenic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Dietary Supplements; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organoselenium Compounds; Selenomethionine; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2012 |
Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase; Humans; Immunoblotting; Immunoprecipitation; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Organoselenium Compounds; Prostatic Neoplasms; Retinoblastoma Protein; S Phase | 2008 |